Emerging Technologies for Improving Phytochemical Bioavailability: Benefits and Risks

被引:22
|
作者
Gurley, B. J. [1 ]
机构
[1] Univ Arkansas Med Sci, Coll Pharm, Dept Pharmaceut Sci, Little Rock, AR 72205 USA
关键词
DRUG-DELIVERY SYSTEMS; SILYMARIN; EXTRACTS; CURCUMIN; DISSOLUTION; VOLUNTEERS; PIPERINE; EFFICACY; BRAIN;
D O I
10.1038/clpt.2011.51
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past two decades, the usage of botanical dietary supplements has steadily increased worldwide. This growing popularity has been especially notable among people in Western countries, where almost 20% of consumers report regular usage of such supplements. 1 Despite their popularity, demonstrable efficacy has remained elusive for many of these agents. 2,3 To improve the efficacy of these agents, researchers and manufacturers have begun adopting novel drug formulation technologies to enhance phytochemical bioavailability (Table 1). However, improved absorption of pharmacologically active phytochemicals may also augment the risk of adverse effects.
引用
收藏
页码:915 / 919
页数:5
相关论文
共 50 条
  • [21] Relationship between dissolution and bioavailability for nimodipine colloidal dispersions: The critical size in improving bioavailability
    Fu, Qiang
    Kou, Longfa
    Gong, Cheng
    Li, Mo
    Sun, Jin
    Zhang, Dong
    Liu, Meina
    Sui, Xiaofan
    Liu, Kai
    Wang, Siling
    He, Zhonggui
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 427 (02) : 358 - 364
  • [22] Emerging Technologies in Ultrasonic and Pneumatic Lithotripsy
    Wollin, Daniel A.
    Lipkin, Michael E.
    UROLOGIC CLINICS OF NORTH AMERICA, 2019, 46 (02) : 207 - +
  • [23] Are There Benefits and Risks to Biosimilars from a Patient Perspective?
    Kay, Jonathan
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2019, 45 (03) : 465 - +
  • [24] The Benefits and Risks of Antioxidant Treatment in Liver Diseases
    Gheorghe, Gina
    Stoian, Anca Pantea
    Gaman, Mihnea-Alexandru
    Socea, Bogdan
    Neagu, Tiberiu Paul
    Stanescu, Ana Maria Alexandra
    Bratu, Ovidiu Gabriel
    Mischianu, Dan Liviu Dorel
    Suceveanu, Andra Iulia
    Diaconu, Camelia Cristina
    REVISTA DE CHIMIE, 2019, 70 (02): : 651 - 655
  • [25] Risks and benefits with bevacizumab: evidence and clinical implications
    Kurkjian, Carla
    Kim, Edward S.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2012, 3 (02) : 59 - 69
  • [26] The risks and the benefits of mesalazine as a treatment for ulcerative colitis
    Moss, Alan C.
    Peppercorn, Mark A.
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (02) : 99 - 107
  • [27] Antiarrhythmic Drugs Check lot Risks and Benefits
    Mankad, Pranav
    Kalahasty, Gautham
    MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (05) : 821 - +
  • [28] Environmental risks and the potential benefits of nanopesticides: a review
    Xu, Zhenlan
    Tang, Tao
    Lin, Qin
    Yu, Jianzhong
    Zhang, Changpeng
    Zhao, Xueping
    Kah, Melanie
    Li, Lingxiangyu
    ENVIRONMENTAL CHEMISTRY LETTERS, 2022, 20 (03) : 2097 - 2108
  • [29] Vitrectomy for vitreous floaters: analysis of the benefits and risks
    Sommerville, Drew N.
    CURRENT OPINION IN OPHTHALMOLOGY, 2015, 26 (03) : 173 - 176
  • [30] Editorial: Risks and Benefits of Adjuvants to Cancer Therapies
    Dong, Peixin
    Gewirtz, David A.
    FRONTIERS IN ONCOLOGY, 2022, 12